Compositions and methods for increasing serum half-life of Fc fusion proteins.

Details for Australian Patent Application No. 2010325943 (hide)

Owner Acceleron Pharma Inc.

Inventors Seehra, Jasbir; Knopf, John; Kumar, Ravindra

Agent Shelston IP

Pub. Number AU-A-2010325943

PCT Pub. Number WO2011/068993

Priority 61/266,095 02.12.09 US; 61/327,582 23.04.10 US

Filing date 2 December 2010

Wipo publication date 9 June 2011

International Classifications

C07K 19/00 Hybrid peptides

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

21 June 2012 PCT application entered the National Phase

  PCT publication WO2011/068993 Priority application(s): WO2011/068993

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010325951-Hinge-integrated adjustable door stop

2010325926-Container and system for decontaminating a medical device with a fog